The big picture: Lupin Dental, operating as French company Digicuto SAS, has completed a €15 million Series A financing round. The funding was led by private equity firm Fynveur, advised by Invus, with a direct investment of €10 million. Existing shareholders, new private investors, and a loan from Bpifrance also participated. Lupin Dental aims to transform dental care through innovative robotic systems.
Why it matters:
- Market Growth: The robotic dentistry market is projected to reach between $1.4 billion and $2.6 billion by 2033 or 2034, with annual growth rates of 12.9% to 18%.
- Expertise Replication: Lupin’s system allows general dentists to replicate the precision and skills of highly experienced aesthetic dentists, standardizing complex procedures.
- Global Expansion: The funding will support Lupin’s efforts to establish partnerships and expand the use of its robotic system, particularly as it seeks regulatory approvals in major markets.
How it works:
- Automated Preparation: The Lupin Robotic System is an automated platform designed to assist in minimally invasive tooth preparation for veneers, with a dentist overseeing the procedure.
- Precision Software: The system’s software generates a patient’s desired smile and forms a precise treatment plan, which the robot then executes under supervision.
- Skill Transfer: By digitizing the practical skills refined by founders Stefen Koubi and Galip Güreli over decades, the system enables dentists without extensive specialist experience to achieve high levels of accuracy.
The catch: While Lupin Dental’s system is approved in India and the UK, it has not yet secured regulatory clearance for use in the United States or the EU, two of the world’s largest dental markets. This regulatory hurdle could slow its market penetration compared to competitors like Neocis, whose Yomi robot is already used for guided implant surgery, or Perceptive, which has raised $30 million for a fully automated system. The crowded dental AI and robotics sector, with significant investments in companies like Pearl ($58M Series B) and Trust AI ($6M), suggests that regulatory approval, rather than just technological innovation, will be a key differentiator and competitive battleground.
Key Facts
- Company: Lupin Dental
- Amount: €15M
- Round: Series A
- Investors: Fynveur (lead), Bpifrance
- Founders: Stefen Koubi, Galip Güreli
- Sector: Robotic Dentistry
- Headquarters: Montpellier, France
